FDA Medical devices recall ·

Quest Spectrum 3 Fluorescent Imaging System Model recall

Recall number
Z-0232-2025
Date
(initiated September 24, 2024)
Company / brand
Olympus Corporation of the Americas
3500 Corporate Pkwy, Center Valley, PA, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
3 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Quest Spectrum 3 Fluorescent Imaging System Model/Catalog Number: ART-SYS-0029, ART-SYS-0030 The Quest Spectrum3 is a fluorescent imaging system used in capturing and viewing fluorescent images for the visual assessment of blood flow for the evaluation of tissue perfusion, and related tissue-transfer circulation in tissue and free flaps used during plastic and reconstructive surgeries.

Why was it recalled?

Does not meet the requirements for electromagnetic compatibility (EMC) of the standard IEC 60601-1-2. Electromagnetic interference occurring during a procedure may cause the device to malfunction requiring the replacement of the device. This could potentially result in a prolonged procedure and/or require additional medical intervention

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

UDI-DI: 08719324487047 Lot Code: Model: ART-SYS-0029, Serial: ART-SYS-2022-F04, ART-SYS-2022-A06, ART-SYS-2022-F05; Model: ART-SYS-0030; No distribution in the USA

Distribution

OH

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-0232-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.